Navigation Links
AbbVie To Present Investigational Data From Phase II Hepatitis C Program At The Liver Meeting
Date:10/1/2013

V Development Program
The AbbVie HCV clinical development program is intended to advance scientific knowledge by investigating an interferon-free, all-oral DAA regimen with the goal of producing high SVR rates in as many patients as possible, including those typically most difficult to cure. The large, multinational HCV program includes more than 2,200 patients from 30 countries.

AbbVie's hepatitis C portfolio includes investigational medicines with three different mechanisms of action targeting areas of the viral replication process including boosted protease inhibitor (ABT-450), polymerase (ABT-333) inhibitor and NS5A (ABT-267) inhibitor, currently being studied in clinical trials. ABT-450/r is co-formulated with ABT-267.

Details of AbbVie's phase III clinical programs are as follows: StudyPatients (n)Treatment RegimenTreatment DurationSAPPHIRE I

GT1, treatment-naïve

(600*)

ABT450/r +ABT267**

ABT333

Ribavirin

12 weeksSAPPHIRE II

GT1, treatment-experienced

(400*)

ABT450/r +ABT267**

ABT333

Ribavirin

12 weeksPEARL II

GT1b, treatment-experienced

(210*)

ABT450/r +ABT267**

ABT333

Ribavirin

12 weeks

SOURCE AbbVie Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. AbbVie and Galapagos to Co-Develop Cystic Fibrosis Therapies
2. Strong Sales and Healthcare Reforms Benefit Earnings - Research Report on Gilead, Pfizer, Merck, AbbVie, and LifePoint
3. After Reviewing Brief Product Profiles, Surveyed Physicians Believe that Likely Candidates for Late-Phase Chronic Kidney Disease Products from AbbVie, Mitsubishi Tanabe, Eli Lilly, Concert, Fibrogen and Pfizer are Typically Stage 3b and 4 Patients
4. AbbVie Declares Quarterly Dividend
5. AbbVie Presents Preliminary Results from Phase I Study of Investigational Oncology Compound ABT-199/GDC-0199 in Patients with High-Risk Chronic Lymphocytic Leukemia (CLL) at European Hematology Association Annual Meeting
6. For Treating Psoriatic Arthritis, Clinical Data and Thought Leaders Opinions Indicate that AbbVie/Eisais Humira Has the Best Clinical Profile Among Key Marketed Therapies
7. AbbVie to Participate in 2013 Jeffries Global Healthcare Conference
8. AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy
9. AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohns Disease
10. AbbVie to Present Data on Investigational Anti-Cancer Compounds at American Society of Clinical Oncology Annual Meeting
11. AbbVie and Alvine to Collaborate on Investigational Oral Therapy for Celiac Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... N.C. , Feb. 27, 2015 Pharmaceutical ... of managing multiple products for the same indication. This ... those that want to prevent one of their brands ... According to recent research by benchmarking firm, ... products as independent brands rather than together as part ...
(Date:2/27/2015)... , Feb. 27, 2015  Acsis Inc., the market ... solutions, announced today that John DiPalo , Acsis, ... Supply & Demand Chain Executive 2015 Provider Pro ... are leading initiatives to help prepare their companies, and ... business climate. This year,s list of Provider Pros to ...
(Date:2/27/2015)... HOUSTON, TX , Feb. 27, 2015 /PRNewswire/ ... and Bloom Burton & Co. Ltd. ("Bloom Burton") today ... (the "Lock-Up") 2,353,130 common shares of the Company ("Common ... to the Lock-Up. Of the Common Shares released from ... upon release from the Lock-Up while the remainder will ...
Breaking Medicine Technology:New Report Details How to Expand a Pharmaceutical Product Portfolio without Cannibalizing an Established Brand 2Acsis CSO John DiPalo Named Supply & Demand Chain Executive 2015 Pro to Know 2ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 2ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 3ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 4
... CITY, Calif., Feb. 8, 2012 Cardica, Inc. (Nasdaq: ... public offering of 9,091,000 shares of its common stock, offered ... The gross proceeds to Cardica from this offering are expected ... and other estimated offering expenses payable by Cardica.  The offering ...
... (NASDAQ: MLAB ) today reported a 21 percent increase in ... fiscal third quarter ended December 31, 2011. Highlights: ... to $1,987 ,000 Quarterly revenues increased 21% year over ... sales growth in the fiscal third quarter Quarterly non-GAAP ...
Cached Medicine Technology:Cardica Prices Public Offering of Common Stock 2Mesa Labs Reports 58 Percent Increase in Third Quarter Net Income 2Mesa Labs Reports 58 Percent Increase in Third Quarter Net Income 3Mesa Labs Reports 58 Percent Increase in Third Quarter Net Income 4Mesa Labs Reports 58 Percent Increase in Third Quarter Net Income 5
(Date:2/28/2015)... The MCA Youth Empowerment Conference aims to bridge youths ... towards the goal for a better future for all ... smaller groups will be held after the conference with ... Healthcare, Social and Volunteerism, Women and Youth Empowerment, to ... , Young adults aged between 18-30 years that have ...
(Date:2/28/2015)... TX (PRWEB) March 01, 2015 Heart ... estimated that 10 percent of urban adult population and ... form of heart diseases and 20-30 percent of them ... to heart ailments and coronary vascular diseases (CVD). , ... launched a new market research report titled “Indian Coronary ...
(Date:2/28/2015)... Gerald “Solutionman” Haman surveyed over 10,000 people to discover ... “The #1 block was lack of time and ... who created the Thinkubator Innovation Studio in Chicago. ... did not have enough time for innovative thinking and ... , Solutionman’s monthly “Accelerating Innovation Training” workshops address the ...
(Date:2/28/2015)... Calgary, AB (PRWEB) February 28, 2015 ... and is now a distributor of the machine. The ... part of their license, like a franchise model. The ... people prevent and reverse heart disease. To buy ... Heart Fit Clinic can help individuals through this process ...
(Date:2/28/2015)... February 28, 2015 March—also known ... time to remind ourselves and others that suspected ... Atlantic NeuroSurgical Specialists (ANS). , Concussions are a ... for 75% of TBIs. There are 1.6-3.8 million ... sound benign, but it is a brain injury. ...
Breaking Medicine News(10 mins):Health News:My Mobile University Appointed Learning Partner for the Upcoming MCA’S First Youth Empowerment Conference Held in Malaysia on March 28, 2015 2Health News:My Mobile University Appointed Learning Partner for the Upcoming MCA’S First Youth Empowerment Conference Held in Malaysia on March 28, 2015 3Health News:My Mobile University Appointed Learning Partner for the Upcoming MCA’S First Youth Empowerment Conference Held in Malaysia on March 28, 2015 4Health News:India Coronary Stent Market 2019 Forecasts Analysis in New Research Report Available at MarketReportsOnline.com 2Health News:India Coronary Stent Market 2019 Forecasts Analysis in New Research Report Available at MarketReportsOnline.com 3Health News:New Survey Reveals “Lack of Time” Is the Number #1 Barrier to Innovative Thinking 2Health News:New Survey Reveals “Lack of Time” Is the Number #1 Barrier to Innovative Thinking 3Health News:Clinicians Can Now Purchase External Counterpulsation with Heart Fit Clinic 2Health News:Atlantic NeuroSurgical Specialists (ANS) Focus on National Brain Injury Awareness Month to Educate the General Public on Head Trauma 2Health News:Atlantic NeuroSurgical Specialists (ANS) Focus on National Brain Injury Awareness Month to Educate the General Public on Head Trauma 3
... PHILADELPHIA, Nov. 6 The American Academy of ... members of Lippincott Williams & Wilkins (LWW) nursing ... Wolters Kluwer Health, a leading provider of information ... in medicine, nursing, allied health, and pharmacy. Academy ...
... groups pay off, study finds , FRIDAY, Nov. ... starting a walking group or creating pedestrian-friendly routes ... study has found. , At a multicultural housing ... interventions meant to increase residents, walking, including sponsoring ...
... St. Michael,s Hospital working in conjunction with EMS services, paramedics ... attempts cardiopulmonary resuscitation (CPR) can quadruple the survival rate to ... research team at Rescu ( www.rescu.ca ) have found only ... help, one of the lowest rates of bystanders helping others ...
... With 125 million Americans challenged by at least one chronic illness ... chronic illnesses, early, smart estate and financial planning can make the ... its exigencies. , WHAT : ... importance for people living with chronic illness and their advisers: ...
... Bermuda, Nov. 6 Allied World Assurance,Company Holdings, ... Allied World U.S.,Nicole Baummer, Assistant Vice President for ... Professional Lines,Claims, will be speaking at this year,s ... held in Chicago, Illinois,November 11-13, 2009. , ...
... tables cleaned less often than toilet seats, study finds ... of restrooms aboard cruise ships raises the risk of ... Norovirus causes about 95 percent of acute gastroenteritis outbreaks ... norovirus outbreaks occurred on 66 ships monitored by the ...
Cached Medicine News:Health News:Seven LWW Nursing Editors Recognized as Leaders by American Academy of Nursing 2Health News:Seven LWW Nursing Editors Recognized as Leaders by American Academy of Nursing 3Health News:Less than 1 in 3 Toronto bystanders who witness a cardiac arrest try to help: Study 2Health News:Less than 1 in 3 Toronto bystanders who witness a cardiac arrest try to help: Study 3Health News:Chronic Illness: Estate Planning 2Health News:Chronic Illness: Estate Planning 3Health News:Chronic Illness: Estate Planning 4Health News:Allied World's Nicole Baummer and Marjorie Thompson to Speak at PLUS International Conference 2Health News:Allied World's Nicole Baummer and Marjorie Thompson to Speak at PLUS International Conference 3Health News:Poor Restroom Cleaning Causes Cruise-Ship Sickness 2
... Eppendorf has created this extremely versatile ... in laboratory liquid handling. With EDOS, high ... are completed with ease. ,The smallest ... of the corresponding Combitip. The easy-to-follow user ...
The WellPro 384 is designed for use with 384 well microplates. It utilizes a 24 channel liquid head and can perform serial dilutions in a 16 or 24 across format, and plate to plate transfers and plat...
Wellpro 96 an automated liquid handling system for 96-well plates that quickly and accurately prepares large quantities of serial dilutions. The Wellpro also performs plate to plate transfers using ...
... workstations is designed for laboratories with limited ... automation platform for routine sample preparation and ... throughput, process consistency and safety. Windows ... you to control the robotic and liquid ...
Medicine Products: